Global Antimicrobial Resistance, Prescribing, and Efficacy Among Neonates and Children

The GARPEC project is a Penta-sponsored global surveillance network focused on collection of data on neonatal and pediatric antimicrobial prescribing and resistance. Its main functions are to collect and analyze data on antimicrobial prescriptions among neonates and children and on the organisms causing blood stream infections in these populations, including their antibiotic/antifungal resistance patterns.

The network addresses the current lack of quality, standardized data on antimicrobial use and resistance among neonatal and pediatric patients, data which are essential for characterizing the problem of antimicrobial resistance worldwide and developing effective treatment and control strategies at the local level.

This project is funded by Penta.